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ABSTRACT

EFFECT OF MELATONIN AND DOPAMINE IN SITE SPECIFIC
PHOSPHORYLATION OF PHOSDUCIN IN INTACT RETINA

Nkemdirim Okere Arinzechukwu
Department of Chemistry and Biochemistry
Master of Science

Phosducin (Pdc) is a 28 kDa binding partner for the G protein βγ subunit dimer
(Gβγ) found abundantly in the photoreceptor cells of the retina and pineal gland. In the
retina, light-dependent changes in cAMP and Ca2+ control the phosphorylation of Pdc at
serine 73 and 54, respectively, which in turn controls the binding of Pdc to Gβγ. Gβγ
binding has been proposed to facilitate light-driven transport of Gβγ from the site of
phototransduction in the outer segment of the photoreceptor cell to the inner segment,
thereby decreasing light sensitivity and contributing to the process of light adaptation.
Dopamine and melatonin are neuromodulators whose concentrations in the retina
vary reciprocally during the circadian cycle, with dopamine high during the day and

melatonin high during the night. Together, they control numerous aspects of light and
dark adaptation in the retina. In this study, we have investigated the possible roles of
dopamine and melatonin in regulating Pdc phosphorylation. Using phosphorylation-site
specific antibodies to serines 54 and 73, we show that dopamine decreases the
phosphorylation of both sites. This decrease is blocked by D4 receptor antagonists and
pertussis toxin, indicating that dopamine causes a decrease in photoreceptor cell cAMP
and Ca2+ concentration via the D4 receptor coupled to the Gi protein. Conversely,
melatonin increases the phosphorylation of both S54 and S73, most likely via the
inhibition of dopamine synthesis. These results demonstrate that dopamine and
melatonin control the phosphorylation state of phosducin by changing the concentration
of cAMP and Ca2+ in photoreceptor cells, and they suggest that dopamine and melatonin
may contribute to the light-induced movement of the photoreceptor G protein by
regulating Pdc phosphorylation.
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CHAPTER 1
INTRODUCTION TO THE ROLE OF PHOSDUCIN IN PHOTOTRANSDUCTION

Vertebrate vision is initiated by a canonical G protein cascade in the outer segment of
photoreceptor cells of the retina, involving the receptor rhodopsin with its 11-cis retinal
chromophore, the photoreceptor G protein transducin (Gt), cGMP phosphodiesterase and
cGMP-gated-cation channels (Arshavsky et al., 2002). The light-induced decrease in
cGMP closes the channels, resulting in a decrease in Na+ and Ca2+ in the outer segment
and a hyperpolarization of the photoreceptor cell plasma membrane. This
hyperpolarization closes voltage-gated Ca2+ channels in the inner segment and synaptic
terminus, blocking glutamate release into the post-synaptic cleft and thereby initiating the
neuronal response.
The light-induced decrease in intracellular Ca2+ triggers a number of molecular
events that decrease the sensitivity of the photoreceptor to light. These include an
increase in guanylyl cyclase activity which restores cGMP concentrations, an increase in
the binding affinity of the cation channels for cGMP which reopens the channels and an
increase in rhodopsin phosphorylation which leads to arrestin binding and rhodopsin
inactivation (Fain et al., 2001). The ability of photoreceptors to light adapt is essential in
maintaining their responsiveness over the broad range of light intensities normally
encountered. In addition to Ca2+-dependent mechanisms, it has been recently proposed
that light-induced translocation of Gt contributes to longer term light adaptation (Sokolov
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et al., 2002). In the dark, Gt is found almost exclusively in the outer segment, associated
with the disc membranes; but in the light Gt redistributes throughout the photoreceptor
cell with the majority in the inner segment as would be expected for a soluble protein
(Sokolov et al., 2002). This redistribution of Gt is associated with a reduction in light
sensitivity (Sokolov et al., 2002). The mechanism of translocation is unknown, but may
involve the interaction of the Gtβγ dimer with phosducin (Pdc) since the translocation of
both Gtα and Gtβγ was disrupted in mice in which the phosducin gene was deleted
(Sokolov et al., 2004).
Pdc is a 28 kDa photoreceptor protein that binds the Gtβγ complex in the light and
dissociates in the dark (Lee et al., 2004; Sokolov et al., 2004). When bound, Pdc blocks
the interaction of Gtβγ with Gtα and with lipid membranes (Yoshida et al., 1994). The
Pdc-Gtβγ interaction is controlled by phosphorylation of Pdc at serines 54 (S54) and 73
(S73) which is in turn controlled by light. In the dark when Ca2+ and cAMP
concentrations are high, S54 is phosphorylated by a Ca2+/calmodulin-dependent protein
kinase (CaMK) and S73 is phosphorylated by cAMP-dependent protein kinase (PKA)
(Lee et al., 2004; Lee et al., 1990). Phosphorylation at both sites creates a binding site for
the phospho-serine binding protein 14-3-3 (Thulin et al., 2001). In its phosphorylated
and 14-3-3 bound form, Pdc can not interact with Gtβγ (Thulin et al., 2001). Light
exposure decreases Ca2+ and cAMP in the photoreceptor (Cohen and Blazynski, 1990;
Krizaj and Copenhagen, 2002; Nir et al., 2002), inhibiting the activity of CaMK and
PKA. Moreover, light increases the rate of dephosphorylation of serine 54 by PP2A by a
yet to be determined mechanism, while dephosphorylation of serine 73 by PP1 occurs in
both the light and dark (Lee et al., 2004). As a result, Pdc is dephosphorylated in
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response to light, which permits a high affinity interaction with Gtβγ. Once bound, Pdc
may facilitate Gtβγ translocation to the inner segment or retain Gtβγ in the inner segment.
In this manner, Pdc may participate in long term light adaptation processes.
Dopamine and melatonin are neuromodulators that coordinate light and dark
adaptation in the retina. Light and circadian day cause a decrease in the synthesis and
release of melatonin from photoreceptor cells (Besharse and Iuvone, 1983; Pang et al.,
1980), which in turn results in an increase in dopamine release from dopaminergic cells
in the inner plexiform layer of the retina (Witkovsky, 2004). The increase in retinal
dopamine concentration contributes to a number of light-adaptive mechanisms in
photoreceptor cells, including the switch from rod to cone-mediated vision (Krizaj and
Wikovsky, 1993; Manglapus et al., 1999). The opposite effects are observed in the dark
and during the circadian night. Thus, melatonin is high at night in the dark and vision is
rod-mediated, while dopamine is high during the day in the light and vision is conemediated (Cahill et al., 1991; Manglapus et al., 1999).
The molecular mechanisms by which dopamine and melatonin exert their effects
on photoreceptor cells are not well established. In the case of dopamine, it is known to
activate D4-type receptors coupled to Gi in mammalian photoreceptor cells resulting in a
decrease in cAMP concentration (Nir et al., 2002). This decrease reduces cAMPdependent protein kinase (PKA) activity, which is believed to be a primary cause of
dopamine effects on photoreceptor cells (Witkovsky, 2004). Melatonin on the other hand
activates MT1 and MT2 receptors that can couple to multiple G-proteins of the Gi and Gq
families (Dubocovich et al., 2004). In the retina, MT1 receptors localize primarily to the
dopaminergic cells and other cell types in the inner retina (Scher et al., 2002).
3

Localization of MT1 receptors to rod photoreceptors has been shown in humans
(Savaskan et al., 2002; Scher et al., 2002), but not in guinea pigs or rats (Fujieda et al.,
1999; Fujieda et al., 2000). Thus, melatonin may exert its effects on photoreceptor cells
directly through MT1 receptors or indirectly by controlling dopamine release in the inner
retina.
The fact that dopamine decreases cAMP levels in photoreceptor cells suggests
that it may regulate phosducin phosphorylation and thereby impact Gβγ translocation and
phototransduction. Similarly, melatonin could also affect phosducin phosphorylation by
controlling cAMP or Ca2+ levels. To test this possibility, the effects of dopamine and
melatonin on the phosphorylation of S54 and S73 of phosducin were measured in intact
bovine retina. The results show that dopamine and melatonin reciprocally regulate the
phosphorylation of S54 and S73, indicating that by modulating cAMP and Ca2+
concentration in photoreceptor cells, they can control the interactions of Pdc with its
binding partners, Gtβγ and 14-3-3.
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CHAPTER 2
EXPERIMENTAL PROCEDURES

Measuring the effects of dopamine and melatonin on Pdc phosphorylation – Bovine eyes
were taken 5 min. post mortem from a local abattoir between 7:00 - 7:30 A.M. Retinas
were removed immediately and cut into four approximately equal pieces in the light.
Two pieces were dark adapted at 23oC in 1.0 ml of HEPES/Ringer’s buffer (10 mM
HEPES pH 7.5, 120 mM NaCl, 0.5 mM KCl, 0.2 mM CaCl2 , 0.2 mM MgCl2, 0.1 mM
EDTA, 10 mM glucose and 1 mM dithiothreitol) with or without 100 µM dopamine-HCl
(SigmaAldrich) or 100 µM melatonin (SigmaAldrich) for one hr in the case of S73
phosphorylation or two hrs in the case of S54 phosphorylation. This amount of dark
adaptation has been previously shown to give maximal Pdc phosphorylation at each site
(Lee et al., 2004). The two remaining retinal pieces were light adapted for 30 min. under
a 60W bulb at 30 cm distance at 23oC. After adaptation, all samples were homogenized
in hypotonic buffer (20 mM HEPES pH 7.5, 10mM EDTA, 1 mM dithiothreithol, 1 µM
microcystin LR and 0.2 mM PMSF) using a tissue tearer (Dremel). This procedure
blocked further phosphorylation/dephoshorylation reactions by diluting the cellular ATP,
chelating the Mg2+ with EDTA and inhibiting phosphatases with microcystin. The
phosphorylation state of Pdc was stable in this buffer for at least 2 hrs (Lee et al., 2004).
Tissue debris was removed by centrifugation at 30,000 x g for 10 min, after which the
supernatants were colleted and protein concentrations were determined using the
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Coomassie Plus Protein Assay Reagent (Pierce). Twelve µg of total protein from each
sample were separated by SDS-PAGE on 12% gels and immunoblotted with a 1:1000
dilution of rabbit primary antibody specifically recognizing either phosphorylated S54 or
phosphorylated S73 (Lee et al., 2004) and a 1:2000 dilution of goat anti-rabbit IgG
peoxidase-conjugated secondary antibody (Calbiochem) as described previously (Lee et
al., 2004). The blots were developed with the ECL Plus chemiluminescence reagent
(Amersham), and the band intensity was quantified using a Storm 860-D phosphorimager
(GE Healthcare) in chemifluorescence mode.
The dopamine concentration-dependence data were fitted by a non-linear least
squares alogorithm to an equation for inhibition of phosphorylation: P = (Pmax – Pmin)/(1 +
[dopamine]/IC50) + Pmin, where P is the level of phosphorylation at a given dopamine
concentration, Pmax is the maximal level of phosphorylation at zero dopamine, Pmin is the
minimal level of phosphorylation at saturating dopamine and IC50 is the dopamine
concentration at half-maximal inhibition. Similarly the melatonin concentrationdependence data were fitted to an equation for activation of phosphorylation: P = (Pmax –
Pmin)/(1 + EC50/[melatonin]) + Pmin, where P is the level of phosphorylation at a given
melatonin concentration, Pmax is the level of phosphorylation at saturating melatonin, Pmin
is the level of phosphorylation at zero melatonin and EC50 is the melatonin concentration
at half-maximal activation.

Determining the effects of dopamine and melatonin antagonists on Pdc phosphorylation
– Retinas were dark adapted as described above with or without 100 µM dopamine and
900µM of the D2 receptor-specific antagonist L-741,626 (Tocris) or 700 µM of the D4
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receptor-specific antagonist L-745,870 trihydrochloride (Tocris). Control samples
contained 0.33% DMSO which served as the vehicle for the D2 and D4 antagonists. In
the case of melatonin, retinas were dark adapted with or without 100 µM Melatonin and
10 µM of the MT1 and MT2 receptor antagonist luzindole (Tocris). Control samples
contained HEPES-Ringer’s buffer as the vehicle for the luzindole. After dark adaptation,
the samples were immunoblotted to determine S54 and S73 phosphorylation as described
above.

Measuring the contribution of Gi and Ca2+ signaling to the changes in Pdc
phosphorylation induced by dopamine and melatonin – To determine if dopamine and
melatonin were acting through Gi signaling, retinas were treated with or without 5 µg/ml
pertussis toxin (PTX) in HEPES/Ringer’s buffer in the presence and absence of 100 µM
dopamine or melatonin during the 1hr (S73) or 2 hrs (S54) dark-adaptation period. After
which, the samples were immunoblotted to determine S54 and S73 phosphorylation as
described above.
To determine if dopamine and melatonin were acting via changes in intracellular
Ca2+, retinas were treated with 50 µM of the cell-permeant Ca2+ chelator BAPTA-AM
(SigmaAldrich) or the 0.33% DMSO vehicle in HEPES/Ringer buffer without Ca2+ in the
presence or absence of 100 µM dopamine or melatonin during the dark-adaptation period.
After which, the samples were immunoblotted to determine S54 and S73 phosphorylation
as described above.
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CHAPTER 3
EXPERIMENTAL RESULTS

Dopamine inhibits phosphorylation of Pdc at S54 and S73: The effects of dopamine on
Pdc phosphorylation at S54 and S73 were determined by treating bovine retinas with
dopamine in both the light and dark-adapted state and measuring the degree of
phosphorylation by immunoblotting with phosphorylation site-specific antibodies (Lee et
al., 2004). As reported by Lee et al. (2004), Pdc phosphorylation at both S73 and S54
was 4-fold less in light-adapted retina compared to dark-adapted retina (Fig. 1). These
differences have been shown to correspond to phosphorylation stoichiometries between
15-20% in the light and 55-70% in the dark for both sites (Lee et al., 2004). Dopamine
had no effect on the low level of phosphorylation in the light, but it caused a 40%
decrease in phosphorylation of both S73 and S54 in the dark (Fig. 1). The decrease in
S73 phosphorylation in response to dopamine is consistent with the reported decrease in
cAMP in photoreceptor cells induced by dopamine (Nir et al., 2002). This decrease in
cAMP would lead to a decrease in PKA-mediated phosphorylation of S73 (Lee et al.,
2004; Lee et al., 1990). In contrast, the decrease in S54 phosphorylation in response to
dopamine could not have been predicted from previous data. Phosphorylation at S54 is
strictly controlled by intracellular Ca2+, through a CaMK (Lee et al., 2004; Thulin et al.,
2001). Therefore, it appears that dopamine is causing a decrease in intracellular Ca2+ in
photoreceptors which in turn results in a decrease in S54 phosphorylation.
8

The concentration dependence of the inhibition of S73 and S54 phosphorylation by
dopamine was also determined (Fig. 1C). Dopamine inhibited S73 phosphorylation with
an IC50 of 1µM and reached a maximal inhibition of 50%.
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Figure 1. Effect of dopamine on Pdc S73
and S54 phosphorylation in light and darkadapted retinas. Bovine retinas were light or
dark-adapted with or without 100 µM
dopamine as described in Methods. Soluble
proteins were extracted from the retina and
equal amounts of protein were separated by
SDS-PAGE and immunoblotted with an
antibody specific to S73 (A) or S54 (B). The
Pdc band intensities were quantified and
normalized to that of the dark-adapted sample
without dopamine. The concentration
dependence of the dopamine-induced inhibition
of S73 and S54 phosphorylation in darkadapted retinas is shown in (C). Bars and
symbols in the graphs represent the average ±
standard error from at least three separate
experiments. The line in (C) represents a nonlinear least squares fit of the data to an
inhibition equation as described in Methods.
The statistical significance relative to the dark
sample without dopamine was determined by a
paired t-test (** P < 0.01). Representative
immunoblots are shown below the graphs.

The IC50 value is in the same concentration range as the estimated dopamine
concentration in the retina in the light (Witkovsky et al., 1993) and the concentration
range required for activation of dopamine receptors (Dearry et al., 1991), indicating that
the dopamine-induced changes in S73 phosphorylation are occurring within a
physiologically significant concentration range. In the case of S54, a higher
concentration of dopamine was required to inhibit S54 phosphorylation. The IC50 was
50 µM and the maximal inhibition was 70 %. The reason for the IC50 difference
between S54 and S73 may be the metabolism of the exogenously added dopamine during
the longer dark-adaptation period for S54 than for S73 (2 hr versus 1 hr, see Methods),
making the actual concentration less than the concentration added.

Dopamine exerts its effects on Pdc phosphorylation through the D4 receptor: Dopamine
receptors of the D2 family are expressed in photoreceptor cells and mediate decreases in
cAMP in response to dopamine. The D4 subtype has been shown to be the receptor
responsible for dopamine signaling in the mouse and rat (Nir et al., 2002; Patel et al.,
2003), but in other species it is not known whether D2 or D4 receptors are involved
(Witkovsky, 2004). To determine whether D2 or D4 receptors mediate the decrease in
Pdc phosphorylation in bovine photoreceptors, retinas were treated with the D2-specific
antagonist L-741,626 or the D4-specific antagonist L-745,870 trihydrochloride in the
presence of dopamine. S73 phosphorylation was unchanged by the D2-specific
antagonist (Fig. 2A). In contrast, the D4-specific antagonist not only blocked the
dopamine-induced decrease in S73 phosphorylation, it also caused a 40% increase in S73
phosphorylation over the unstimulated level (Fig. 2A). These results show that dopamine
10

is acting through the D4 receptor and not the D2 receptor to inhibit Pdc S73
phosphorylation in bovine photoreceptor cells. The increase in S73 phosphorylation
above basal levels upon treatment with the D4-antagonist suggests that either L-745,870
is functioning as an inverse agonist on D4 receptors or that a residual amount of
endogenous dopamine remains in these retinas during the 1 hr dark adaptation period. L745,870 has not been reported to be an inverse agonist for D4 receptors (Patel et al.,
1997; Pillai et al., 1998). Moreover, retinal dopamine levels have been shown to remain
high early in the circadian subjective day in the absence of light (Manglapus et al., 1999)
and all of these experiments were performed early in the day.
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Figure 2. Effect of D2 and D4 receptor-specific antagonists on the dopamine-induced decrease in
Pdc S73 and S54 phosphorylation. Retinas were dark-adapted with 100 µM dopamine and 900 µM of
the D2-specific antagonist L-741,626 or 700 µM of the D4-specific antagonist L-745,870 as indicated.
Phosphorylation of S73 (A) and S54 (B) were determined as in Fig. 1. Bars represent the average ±
standard error from at least three separate experiments. The statistical significance relative to the dark
sample without dopamine was determined by a paired t-test (P < 0.01). Representative immunoblots
are shown below the graphs.

Therefore, it appears that a residual amount of endogenous dopamine is found in these
retinas, causing S73 phosphorylation to be reduced. In the case of S54 phosphorylation,
the D2-specific antagonist again had no effect, while D4-specific antagonist completely
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blocked the dopamine-induced decrease, but it did not cause an increase above the basal
level as was observed with S73 phosphorylation (Fig. 2B). Together, these antagonist
data show that dopamine is acting via a D4 receptor and not a D2 receptor to decrease
S54 and S73 phosphorylation.
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Investigation of the down-stream signaling pathways involved in the dopamine-dependent
decrease in Pdc phosphorylation: The principal signaling mechanism for the D4 receptor
is through Gi inhibition of adenylyl cyclase activity. To determine if Gi is required for
the observed effects of dopamine on Pdc phosphorylation, retinas were pretreated with
pertussis toxin (PTX), which specifically blocks coupling of Gi to receptors as a result of
ADP-ribosylation of the Giα subunit (Bokoch et al., 1983; Codina et al., 1983; Katada
and Ui, 1982). PTX blocked the dopamine-induced decrease in both S73 and S54
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phosphorylation (Fig. 3), demonstrating that Gi is involved in the dopamine response. Gimediated inhibition of S73 phosphorylation is consistent with the classical mechanism of
Gi signaling: inhibition of adenylyl cyclase activity resulting in a decrease in cAMP
concentration and PKA activity. However, the mechanism of Gi-dependent inhibition of
S54 phosphorylation is less obvious and more intriguing. As mentioned above, S54
phosphorylation is strictly dependent on Ca2+ (Lee et al., 2004). Thus, activation of Gi by
the D4 receptor must somehow cause a decrease in photoreceptor Ca2+.
To further assess the role of Ca2+ in the dopamine-dependent decreases in S73 and
S54 phosphorylation, retinas were pretreated with the Ca2+ chelator BAPTA-AM, prior to
the addition of dopamine. In the case of S73, Ca2+ chelation had little effect on S73
phosphorylation, either in the presence or absence of dopamine (Fig. 4A), consistent with
recent data showing no Ca2+ dependence of S73 phosphorylation in intact retina (Lee et
al., 2004).
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sample without dopamine was determined by a paired t-test (* P < 0.05 ** P < 0.01). Representative
immunoblots are shown below the graphs.
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In the case of S54, Ca2+ chelation decreased phosphorylation as expected. In addition,
Ca2+ chelation blocked any further reduction in phosphorylation by dopamine (Fig. 4B),
indicating that the effects of dopamine on S54 phosphorylation required a change in Ca2+.
This result confirms the observation that dopamine is decreasing S54 phosphorylation by
decreasing Ca2+. A potential mechanism by which dopamine may lower photoreceptor
Ca2+ is presented below (discussed in Chapter 4).

Melatonin increases phosphorylation of Pdc at S54 and S73: Melatonin exerts many of
the opposite effects of dopamine on photoreceptor physiology (Dubocovich et al., 2004).
Hence, it was of interest to determine if melatonin treatment would change the
phosphorylation of Pdc. Intact retinas were treated with melatonin under light and darkadaptation conditions and phosphorylation of Pdc at S73 and S54 was measured using the
phosphorylation site-specific antibodies. Melatonin treatment during light adaptation
caused no significant change in the low level of S73 or S54 phosphorylation. On the
other hand, melatonin treatment during dark adaptation increased phosphorylation of both
S73 and S54 by 1.5-fold (Fig. 5). This increase in S73 and S54 phosphorylation
approaches 100 % phosphorylation at these sites because previous studies showed that
S73 and S54 were phosphorylated 55-70 % under similar dark-adaptation conditions in
the absence of melatonin (Lee et al., 2004). A 1.5-fold increase in phosphorylation in the
presence of melatonin would result in 80-100 % phosphorylation of S73 and S54. Unlike
dopamine, the half-maximal effect of melatonin occurred at approximately the same
concentration for both S73 and S54 phosphorylation (10 µM, Fig. 5C). In addition,
effects of melatonin were completely blocked by the MT1 and MT2 receptor antagonist
14

luzindole (Fig. 6), indicating the melatonin-induced increase in S54 and S73 occurs
specifically through melatonin receptors. Thus, melatonin is again opposing the effects
of dopamine on another physiological property of photoreceptor cells.
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Figure 5. Effect of melatonin on Pdc S73
and S54 phosphorylation in light and
dark-adapted retinas. Retinas were light or
dark-adapted with or without 100 µM
melatonin as described in Methods.
Phosphorylation of S73 (A) and S54 (B) were
determined as in Fig. 1. The concentration
dependence of the melatonin-induced
increase in S73 and S54 phosphorylation in
dark-adapted retinas is shown in (C). Bars
and symbols represent the average ± standard
error from at least three separate experiments.
The line in (C) represents a non-linear least
squares fit of the data to an activation
equation as described in Methods. The
statistical significance relative to the dark
sample without melatonin was determined by
a paired t-test (** P < 0.01). Representative
immunoblots are shown below the graphs.
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Figure 6. Effect of a melatonin receptor-specific antagonist on the dopamine-induced decrease in
Pdc S73 and S54 phosphorylation. Retinas were dark-adapted with 100 µM melatonin and 10 µM of
the MT1 and MT2 receptor-specific antagonist luzindole as indicated. Phosphorylation of S73 (A) and
S54 (B) were determined as in Fig. 1. Bars represent the average ± standard error from at least three
separate experiments. The statistical significance relative to the dark sample without melatonin was
determined by a paired t-test (** P < 0.01). Representative immunoblots are shown below the graphs.

Investigation of the down-stream signaling pathways involved in the melatonindependent increase in Pdc phosphorylation: Melatonin receptors have been shown to
exert their effects through multiple G proteins, including Gi, Gq and G16 (Dubocovich et
al., 2004). Therefore, it was important to determine which G protein subtype was
involved in the melatonin-induced increase in S73 and S54 phosphorylation. To assess
the role of Gi, retinas were pretreated with PTX prior to addition of melatonin. The
melatonin-induced increase in S54 and S73 phosphorylation was completely insensitive
to PTX (Fig. 7), very much in contrast to what was observed with dopamine.
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Figure 7. Effect of PTX on the melatonin-induced decrease in Pdc S73 and S54 phosphorylation.
Retinas were treated with 5 µg/ml PTX during the dark adaptation period with melatonin as indicated.
Phosphorylation of S73 (A) and S54 (B) were determined as in Fig. 1. Bars represent the average ±
standard error from at least three separate experiments. The statistical significance relative to the dark
sample without melatonin was determined by a paired t-test (** P < 0.01). Representative immunoblots
are shown below the graphs.

This result shows that Gi is not involved in melatonin signaling in photoreceptors and it
suggests that melatonin is acting via Gq or G16 to enhance Pdc phosphorylation.
However, it is not clear whether melatonin is acting directly on the photoreceptor cells or
whether it exerts its effect indirectly by inhibiting dopamine release from the
dopaminergic cells in the inner retina (discussed in Chapter 4). To investigate the Ca2+
dependence of the melatonin-mediated increase in S54 and S73 phosphorylation, retinas
were pretreated with the Ca2+ chelator BAPTA-AM prior to addition of melatonin. Ca2+
chelation had no effect on the melatonin-induced increase in S73 phosphorylation,
demonstrating that melatonin was acting on S73 by a Ca2+-independent process (Fig. 8A).
S73 phosphorylation is mediated by PKA in a cAMP-dependent manner. Consequently,
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it can be concluded that melatonin treatment of the retina must in some manner cause an
increase in cAMP in the photoreceptor cells. In the case of S54, Ca2+-chelation inhibited
phosphorylation as in Figure 4 and completely blocked the increase in phosphorylation
caused by melatonin (Fig. 8B). This result indicates that the melatonin-induced increase
in S54 phosphorylation is Ca2+-dependent. Hence, melatonin must be inducing an
increase in Ca2+ in photoreceptor cells. Possible mechanisms by which melatonin
increases both photoreceptor cAMP and Ca2+ are discussed in Chapter 4.
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Figure 8. Effect of the Ca2+ chelator BAPTA-AM on the melatonin-induced decrease in Pdc S73 and
S54 phosphorylation. Retinas were treated with 50 µM BAPTA-AM during the dark adaptation period
with dopamine as indicated. Phosphorylation of S73 (A) and S54 (B) were determined as in Fig. 1.
Bars represent the average ± standard error from at least three separate experiments. The statistical
significance relative to the dark sample without melatonin was determined by a paired t-test (** P < 0.01).
Representative immunoblots are shown below the graphs
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CHAPTER 4
MECHANISMS OF DOPAMINE AND MELATONIN-MEDIATED CHANGES

Dopamine and melatonin exert multiple effects on photoreceptor cells that contribute to
the process of light and dark adaptation, respectively (Dubocovich et al., 2004;
Witkovsky, 2004). The results presented in this study indicate that dopamine and
melatonin help control the phosphorylation state of Pdc. Pdc had been shown to be
phosphorylated at S54 and S73 in the dark and dephosphorylated in the light (Lee et al.,
2004). In the dark, Pdc had been shown to bind 14-3-3 protein when S54 and S73 are
phosphorylated (Thulin et al., 2001), while in the light Pdc binds Gtβγ when S54 is
dephosphorylated (Lee et al., 2004). The binding of Pdc to Gtβγ is believed to increase
the solubility of Gtβγ, increasing its movement from the outer segment to the inner
segment of the rod photoreceptor cell in response to light (Sokolov et al., 2004). The
movement of Gt to the inner segment in the light has been shown to decrease the
sensitivity of rods to light, thus contributing to the process of light-adaptation (Sokolov et
al., 2002). Retinal dopamine concentration increases during the day and decreases during
the night in a circadian-driven manner, whereas retinal melatonin concentration varies in
precisely the opposite manner (Manglapus et al., 1999). Thus, it is possible that one way
in which dopamine contributes to light adaptation is by decreasing the phosphorylation of
Pdc, thereby increasing its binding to Gtβγ and decreasing the amount of Gtβγ in the outer
segment. In contrast, melatonin may contribute to dark adaptation by increasing the
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phosphorylation of Pdc, thereby decreasing its binding to Gtβγ and increasing the amount
of Gtβγ in the outer segment. In addition, Pdc shows significant localization in the
synaptic terminal region of photoreceptors (Chen et al., 2005). However, its function
there is unknown. It is possible that dopamine and melatonin could regulate certain
synaptic events by changing the phosphorylation state of Pdc.
The results presented here provide insight into the mechanism by which dopamine
and melatonin control Pdc phosphorylation. The data from Fig. 2 indicate that dopamine
is functioning through a D4 receptor. D4 receptors have been localized to the
photoreceptor cells in mice and rats (Nir et al., 2002; Patel et al., 2003), suggesting that
dopamine exerts its effect directly on the photoreceptor cells by binding to D4 receptors
on their surface. In the case of S73, dopamine would decrease phosphorylation via a
classical Gi pathway. The dopamine-liganded D4 receptor would activate Gi which
would inhibit adenylyl cyclase, decreasing the concentration of cAMP. This decrease in
cAMP would decrease PKA activity resulting in a decrease in S73 phosphorylation. This
hypothesis is supported by the data of Fig. 3, showing that the dopamine-dependent
decrease in S73 phosphorylation is inhibited by PTX treatment.
The mechanism by which dopamine decreases S54 phosphorylation appears more
complex. S54 has been shown to be phosphorylated in a strictly Ca2+ dependent manner
by a CaMK (Lee et al., 2004; Thulin et al., 2001). Moreover, Pdc is only found in the
cytosol of photoreceptor cells and is not localized to any other cell types in the retina
(Chen et al., 2005; Lee et al., 1988; Thulin et al., 1999). In light of these facts, dopamine
must cause a decrease in intracellular Ca2+ in photoreceptor cells. Current understanding
of Ca2+ handling in photoreceptors suggests only one way by which dopamine could
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cause a decrease in Ca2+ concentration: through the effects of Gi on voltage-gated Ca2+
channels (Krizaj and Copenhagen, 2002). L-type Ca2+ channels are the predominant
voltage-gated Ca2+ channels expressed in photoreceptor cells (Krizaj and Copenhagen,
2002). These channels can be inhibited by Gi indirectly by a decrease in PKA-dependent
phosphorylation of the channels (Carbone et al., 2001; van der Heyden et al., 2005).
Alternatively, L-type channels have been reported in some cellular systems to be
inhibited by Gi directly (Carbone et al., 2001), probably via Gβγ inhibition as is the case
with N-type and P/Q type voltage-gated Ca2+ channels (Herlitze et al., 1996; Ikeda,
1996). Either way, dopamine acting through the D4 receptor and Gi would inhibit L-type
Ca2+ channels, resulting in a decrease in intracellular Ca2+ concentration. This decrease
in Ca2+ may contribute to the dopamine-dependent desensitization of photoreceptors,
given the multiple events that decrease photoreceptor sensitivity to light upon a decrease
in cytosolic Ca2+.
In the case of melatonin, it could increase Pdc phosphorylation by binding to MT
receptors expressed in photoreceptor cells, or it could do so indirectly by binding to MT
receptors expressed in dopaminergic cells in the inner retina and inhibit dopamine release
from those cells. MT receptors have not been localized in the bovine retina, but in other
species they are found in the horizontal, amacrine and ganglion cells of the inner retina
(Fujieda et al., 1999; Fujieda et al., 2000; Savaskan et al., 2002; Scher et al., 2002). They
have also been found in the photoreceptor cells of the human retina (Savaskan et al.,
2002; Scher et al., 2002), but not in the photoreceptors of rat or guinea pig (Fujieda et al.,
1999; Fujieda et al., 2000). Thus, it is not clear whether bovine photoreceptors have
melatonin receptors. MT receptors have been shown to couple to the Gi and Gq families
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of G-proteins (Dubocovich et al., 2004). Thus, the Ca2+-dependent increase in S54
phosphorylation caused by melatonin (Fig. 7 and 8) could result from activation of MT
receptors on the photoreceptor cells working through Gq to increase Ca2+. However, the
cAMP-dependent increase in S73 phosphorylation does not appear to result from direct
activation of MT receptors. In order to increase cAMP over the one hour time course of
these experiments, MT receptors would have to couple to Gs, but they do not normally
activate Gs. MT receptors have only been shown to couple to Gs in heterologous overexpression experiments (Chan et al., 2002).
There appears to be more evidence for an indirect effect of melatonin on Pdc
phosphorylation through the inhibition dopamine release from cells in the inner retina.
For example, the effects of melatonin treatment were exactly the opposite of those caused
by the addition of dopamine, as would be expected if the retinal dopamine concentration
were decreased by melatonin. Moreover, the increase in S73 phosphorylation in the
presence of the D4-receptor antagonist L-745,870 suggests that the retinas contained
residual amounts of dopamine. These bovine retinas were collected and processed during
the morning hours, a time when retinal dopamine concentration is increasing, even during
dark-adaptation (Manglapus et al., 1999). Furthermore, a melatonin-induced decrease in
dopamine could account for the increase in S73 phosphorylation that can not be
explained by a direct effect of melatonin on the photoreceptors themselves. However, the
melatonin-mediated increase in S73 phosphorylation was insensitive to PTX treatment
and Ca2+ chelation, which would block signaling of MT receptors through both of their
established G protein partners, Gi and Gq. It is possible that melatonin could inhibit
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dopamine release via a G-protein independent pathway such as β-arrestin-mediated
activation of mitogen-activated protein kinases (Lefkowitz and Shenoy, 2005).
Although the detailed mechanisms of action remain to be resolved, this study clearly
shows that dopamine inhibits the Pdc phosphorylation at S54 and S73 in intact retina and
that melatonin reverses that effect. Given the close coupling of S54 phosphorylation to
Ca2+ concentration and S73 phosphorylation to cAMP concentration, it can also be
concluded that dopamine decreases Ca2+ and cAMP in the cytosol of the photoreceptor
cell while melatonin increases their concentration. A dopamine-dependent decrease in
cAMP has been shown (Nir et al., 2002), but the dopamine-mediated decrease in Ca2+
was previously unknown, as were the melatonin-induced increases in cAMP and Ca2+. It
seems likely that most of the adaptive effects of dopamine and melatonin on
photoreceptor cells are mediated through changes in the concentration of these important
second messengers.
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